worldwid
spread
avian
influenza
increas
report
resist
current
drug
made
high
prioriti
develop
new
antiinfluenza
drug
owe
uniqu
function
assist
virus
bind
cellular
surfac
key
step
subsequ
penetr
infect
cell
hemagglutinin
ha
becom
one
main
target
drug
design
influenza
viru
develop
potent
ha
inhibitor
zinc
fragment
databas
search
find
optim
compound
core
hop
techniqu
result
compound
obtain
shown
subsequ
molecular
dock
studi
molecular
dynam
simul
assum
favor
conform
bind
pocket
ha
also
stronger
bind
interact
receptor
accordingli
may
becom
promis
candid
develop
new
power
drug
treat
influenza
least
find
report
may
provid
use
insight
stimul
new
strategi
area
recent
year
sever
flulik
human
case
report
around
world
subsequ
caus
viru
identifi
influenza
viru
viru
spread
rapidli
around
world
identifi
new
reassort
three
genet
lineag
mainli
swine
origin
therefor
call
swineorigin
influenza
viru
soiv
owe
extrem
rapid
humantohuman
transmiss
rate
within
two
month
soiv
detect
throughout
entir
world
june
world
health
organ
declar
offici
pandem
first
pandem
centuri
influenza
viru
belong
orthomyxovirida
famili
negativestrand
segment
rna
viru
surfac
membran
protein
constitut
three
import
compon
proton
channel
hemagglutinin
ha
neuraminidas
na
proton
channel
respons
proton
conduct
vital
import
viral
replic
ha
respons
bind
surfac
infect
cell
trimer
lead
attach
subsequ
penetr
virus
target
cell
na
respons
cleav
termin
sialic
acid
moieti
receptor
facilit
elut
progeni
virion
infect
cell
therefor
three
compon
target
drug
design
influenza
viru
recent
stimul
success
determin
highresolut
threedimension
structur
mani
discuss
channel
made
regard
two
exist
drug
amantadin
symmetrel
rimantadin
flumadin
approv
fda
longer
effect
inefficaci
influenza
viru
sialic
acid
sa
natur
ligand
combin
glycoprotein
ha
na
locat
membran
host
cell
basi
hemeagglutin
virus
mix
blood
cell
entri
viru
cell
upper
respiratori
tract
accord
mutagen
analysi
residu
na
bind
site
quit
conserv
influenza
strain
owe
deep
activ
site
cleft
na
attract
target
drug
design
zanamivir
oseltamivir
design
modifi
sialic
acid
sa
structur
two
fdaapprov
clinic
drug
success
use
inhibit
spread
influenza
viral
progeni
bind
viral
surfac
glycoprotein
neuraminidas
na
howev
also
found
sever
clinic
case
oseltamivir
fail
treat
avian
influenza
viru
antigen
drift
sequenc
base
mutat
antigen
shift
genet
recombin
segment
rna
genom
influenza
virus
caus
na
inhibitor
resist
ha
facilit
viral
entri
bind
host
surfac
sialic
acid
residu
accordingli
ha
block
sialic
acid
bind
site
small
molecul
viral
entri
process
stop
penetr
virus
host
cell
prevent
comparison
na
inhibitor
ha
inhibitor
usual
effect
inhibit
influenza
viru
ha
subtyp
far
identifi
subtyp
recent
pandem
viru
taken
target
constitu
screen
drug
design
despit
mani
year
scientif
research
effort
far
clinic
avail
inhibitor
hand
mani
studi
indic
comput
approach
structur
bioinformat
molecular
dock
pharmacophor
model
identif
proteas
type
hiv
proteas
cleavag
site
predict
time
provid
use
inform
insight
drug
develop
encourag
aforement
studi
present
studi
initi
attempt
find
new
antiinfluenza
compound
screen
fragment
databas
optim
constitu
inhibitor
meanwhil
techniqu
core
hop
glide
dock
molecular
dynam
simul
also
util
analyz
bind
interact
inhibitor
hope
find
thu
obtain
use
develop
new
power
drug
influenza
viru
crystal
structur
subtyp
recent
pandem
viru
download
pdb
bank
pdb
id
antigen
swineorigin
influenza
viru
quit
similar
ha
pandem
viru
bindingsit
identifi
sitemap
tool
schroding
suit
wwwschrodingercom
describ
bindsit
encompass
ligand
nacetyldglucosamin
nag
observ
complex
crystal
structur
pdb
shown
fig
closeup
view
bind
site
protein
render
molecular
surfac
bind
pocket
form
residu
least
one
heavi
atom
ie
atom
hydrogen
distanc
away
heavi
atom
nag
ligand
bound
receptor
bind
site
elabor
segment
play
import
role
interact
ligand
shown
four
differ
color
respect
key
residu
fig
motion
four
residu
monitor
molecular
dynam
simul
druglik
databas
fragment
databas
deriv
zinc
use
virtual
screen
core
hop
search
respect
dock
program
interfac
schroding
suit
use
screen
druglik
databas
zinc
base
structur
prepar
refin
protocol
protein
receptor
compound
structur
perform
protein
prepar
wizard
ligprep
modul
embed
schroding
respect
protein
prepar
process
includ
assign
bond
order
ad
hydrogen
treat
metal
treat
disulfid
delet
water
allevi
potenti
steric
clash
adjust
bond
order
formal
charg
protein
minim
forc
field
constrain
refin
valu
rmsd
protein
limit
meanwhil
compound
prepar
consist
gener
possibl
state
ioniz
target
ph
desalt
retain
chiral
structur
geometri
minim
forc
field
step
accomplish
investig
compound
dock
receptor
pocket
rigid
dock
model
standprecis
sp
score
function
estim
bind
affin
mani
use
clue
drug
design
achiev
molecular
dock
studi
see
eg
order
gain
even
use
inform
regard
novel
drug
design
algorithm
call
core
hop
use
studi
function
perform
fragmentbas
replac
molecular
dock
method
particularli
use
de
novel
drug
design
improv
activ
templat
compound
studi
lead
compound
screen
druglik
databas
templat
taken
initi
structur
subject
optim
via
core
hop
method
find
optim
core
attach
scaffold
part
templat
bind
protein
receptor
process
core
hop
first
step
defin
point
core
attach
scaffold
perform
defin
combin
step
combinatori
screen
panel
second
step
defin
receptor
grid
file
done
receptor
prepar
panel
third
step
prepar
core
attach
scaffold
fragment
databas
deriv
zinc
final
core
thu
obtain
sort
filter
good
align
redock
receptor
attach
scaffold
follow
use
dock
score
sort
final
molecul
mani
marvel
biolog
function
protein
dna
profound
dynam
mechan
switch
activ
inact
state
cooper
effect
alloster
transit
intercal
drug
dna
assembl
microtubul
reveal
bind
pocket
defin
residu
least
one
heavi
atom
distanc
nag
ligand
four
loop
play
import
role
interact
ligand
repres
round
ribbon
four
differ
color
well
key
residu
respect
motion
four
residu
monitor
molecular
dynam
simul
dock
pose
neo
shown
stick
model
color
purpl
yellow
dark
green
respect
studi
intern
motion
likewis
realli
understand
action
mechan
receptor
ligand
consid
static
structur
concern
also
dynam
inform
obtain
simul
intern
motion
dynam
process
order
examin
whether
design
inhibitor
remain
bound
presenc
explicit
solvent
dynam
point
view
molecular
dynam
simul
perform
gromac
forc
field
period
boundari
condit
pbc
use
gromac
packag
linux
topolog
file
charg
ligand
atom
gener
dunde
server
beta
start
simul
model
solvat
explicit
simpl
point
charg
spc
water
cubic
box
model
cover
water
shell
nm
surfac
protein
system
neutral
six
chlorin
ion
replac
six
spc
water
molecul
subsequ
energi
minim
perform
system
concern
use
steepest
descent
touch
toler
ns
md
simul
carri
time
step
fs
correspond
coordin
store
everi
fs
pme
algorithm
use
calcul
electrostat
interact
simul
run
period
boundari
condit
nvt
ensembl
use
berensen
coupl
algorithm
keep
temperatur
k
pressur
bond
constrain
use
linc
algorithm
gromac
packag
util
analyz
result
druglik
databas
zinc
screen
use
nearoptim
perform
aim
target
receptor
pdb
top
hit
acetamid
fig
compound
condens
product
glycin
adenin
consid
potenti
lead
compound
modif
subsequ
core
hop
method
employ
search
fragment
databas
replac
adenin
part
final
new
structur
neo
discov
strong
affin
flowchart
show
process
find
desir
inhibitor
given
fig
see
screen
zinc
druglik
databas
core
hop
method
use
optim
mean
search
zinc
fragment
databas
bind
affin
nag
receptor
use
filter
set
result
compound
top
hit
neo
select
optim
shown
fig
rigid
fragment
neo
stick
activ
pocket
might
well
adher
activ
pocket
surfac
improv
bind
affin
target
protein
bond
cn
cut
site
shown
fig
consequ
pyridin
remain
whole
structur
flexibl
enhanc
abil
stretch
complement
surfac
bind
site
new
scaffold
build
block
optim
second
core
hop
process
replac
variou
fragment
search
fragment
databas
interestingli
best
substitut
also
contain
glycin
termin
fragment
side
neo
subsequ
seri
compound
candid
modifi
neo
structur
gener
top
ten
compound
best
bind
affin
comput
program
list
fig
seen
fig
result
obtain
dock
simul
prove
compound
bind
interact
residu
fulli
consist
previou
report
structur
complement
shallow
pocket
optim
conform
side
chain
key
residu
protein
made
major
contribut
receptorligand
bind
affin
form
hbond
differ
heavi
atom
eg
n
fig
besid
common
hbond
form
three
residu
compound
two
hbond
form
two
nitrogen
atom
new
extens
fragment
oxygen
atom
residu
consequ
compar
bind
affin
receptor
strengthen
kcalmol
kcalmol
fig
furthermor
molecular
dynam
simul
perform
inhibitorcomplex
system
inhibitoruncomplex
system
respect
root
mean
squar
deviat
rmsd
initi
conform
central
criterion
use
evalu
differ
protein
system
stabil
simul
system
evalu
base
rmsd
rmsd
valu
green
curv
red
curv
versu
simul
time
illustr
fig
rmsd
system
littl
smaller
system
indic
flexibl
decreas
bind
order
investig
motion
import
residu
interact
inhibitor
bind
site
defin
loop
fig
root
mean
squar
fluctuat
rmsf
sidechain
atom
protein
calcul
shown
fig
curv
rmsf
associ
color
orang
light
blue
dark
blue
maroon
respect
clearli
seen
fig
fluctuat
magnitud
four
loop
much
larger
clearli
indic
receptor
stabl
bind
ligand
rmsd
backbon
atom
system
green
system
red
b
rmsf
sidechain
atom
system
green
system
red
curv
associ
color
orang
light
blue
dark
blue
maroon
respect
accordingli
among
seri
neo
compound
candid
anticip
promis
drug
candid
experiment
investig
develop
new
effect
drug
influenza
virus
